CODES, a novel procedure for ligand-based virtual screening:: PDE7 inhibitors as an application example

被引:33
作者
Castro, Ana [1 ]
Jose Jerez, Maria [1 ]
Gil, Carmen [1 ]
Calderson, Felix [1 ]
Domenech, Teresa [2 ]
Nueda, Arsenio [2 ]
Martinez, Ana [1 ]
机构
[1] CSIC, Inst Quim Med, E-28006 Madrid, Spain
[2] Res Ctr, Dept Biol, Barcelona 08980, Spain
关键词
PDE7; virtual screening; CODES;
D O I
10.1016/j.ejmech.2007.10.027
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Phosphodiesterase (PDE) 7 is a high affinity cAMP-specific PDE whose functional role in T-cells has been the subject of some controversy. Recent findings on tissue distribution, however, support the hypothesis that PDE7 could be a good target for the treatment of airway diseases, T-cell related diseases or central nervous system (CNS) disorders. Therefore, the identification of selective inhibitors targeted against PDE7 enzyme has become an attractive area of research. We report here the first use of the descriptors generated by the CODES program for ligand-based virtual screening. This program codifies molecules from a topological point of view and the generated descriptors are related to the chemical nature of the atoms, the atomic bonds and the connectivity with the rest of the molecule. They are also able to distinguish among stereoisomers. By using this approach, 173 compounds were codified, and their similarity with the reference compound was analysed. Based on the analysis, new potential PDE7 inhibitors have been identified, synthesized and biologically evaluated confirming that CODES descriptors are valid for ligand-based virtual screening and provided new lead compounds for further optimization as potent and selective PDE7 inhibitors. (c) 2007 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1349 / 1359
页数:11
相关论文
共 52 条
[1]   Immunosuppressive drugs, the first 50 years and a glance forward [J].
Allison, AC .
IMMUNOPHARMACOLOGY, 2000, 47 (2-3) :63-83
[2]   Molecular similarity and property similarity [J].
Barbosa, F ;
Horvath, D .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (06) :589-600
[3]   THE INVENTION OF NEW RADICAL CHAIN-REACTIONS .9. FURTHER RADICAL CHEMISTRY OF THIOHYDROXAMIC ESTERS - FORMATION OF CARBON CARBON BONDS [J].
BARTON, DHR ;
CRICH, D ;
KRETZSCHMAR, G .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1986, (01) :39-53
[5]   Molecular surface point environments for virtual screening and the elucidation of binding patterns (MOLPRINT 3D) [J].
Bender, A ;
Mussa, HY ;
Gill, GS ;
Glen, RC .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (26) :6569-6583
[6]   SYNTHESIS OF SOME S-SUBSTITUTED-2-MERCAPTO-3ARYL-4-QUINAZOLONES [J].
BHARGAVA, PN ;
RAM, P .
BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN, 1965, 38 (03) :342-+
[7]   Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries [J].
Birk, S ;
Edvinsson, L ;
Olesen, J ;
Kruuse, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 489 (1-2) :93-100
[8]   Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: Advances in the development of specific phosphodiesterase inhibitors [J].
Castro, A ;
Jerez, MJ ;
Gil, C ;
Martinez, A .
MEDICINAL RESEARCH REVIEWS, 2005, 25 (02) :229-244
[9]   CoMFA of benzyl derivatives of 2,1,3-benzo and benzothieno[3,2-a]thiadiazine 2,2-dioxides:: clues for the design of phosphodiesterase 7 inhibitors [J].
Castro, A ;
Abasolo, MI ;
Gil, C ;
Segarra, V ;
Martinez, A .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2001, 36 (04) :333-338
[10]  
Choo HYP, 2002, BIOORGAN MED CHEM, V10, P517